Pausing immunosuppression improves COVID-19 booster response: study
UK doctors say suspension of methotrexate therapy enhances vaccine-induced immunity
A two-week interruption to methotrexate therapy can double the antibody response to COVID-19 booster vaccines in adults with immune-mediated inflammatory diseases, new research shows.
Although this short drug holiday was associated with more disease flare-ups, UK clinicians say most were self-managed and had no adverse impact on patient quality of life.
“This intervention is simple, low-cost, and easy to implement, and could potentially translate to increased vaccine efficacy and duration of protection for susceptible groups,”
